EVANSTON, Ill.--(BUSINESS WIRE)--Northfield Laboratories Inc. (Nasdaq: NFLD) announced today that Richard D. Newman, Ph.D., D.A.B.T., will assume a leadership role for the Company in Regulatory Affairs. Dr. Newman has served as a consultant to Northfield on all aspects of regulatory matters since 2003. Eva Essig, Ph.D., who previously served in this role, has accepted a regulatory position in the pharmaceutical industry.
